Literature DB >> 27692477

NICE guidance on necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer.

Nwamaka Umeweni1, Helen Knight2, Gary McVeigh2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27692477     DOI: 10.1016/S1470-2045(16)30488-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.

Authors:  Hamzeh Albaba; Charles Lim; Natasha B Leighl
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

2.  Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan.

Authors:  Kaori Hisanaga; Hiroshi Uchino; Naoko Kakisu; Masahiko Miyagi; Fukumi Yoshikawa; Genki Sato; Kazutoshi Isobe; Kazuma Kishi; Sakae Homma; Takahisa Hirose
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-22       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.